Perkins Capital Management »

Puma Biotechnology shares owned by Perkins Capital Management

Quarter-by-quarter ownership of Puma Biotechnology (PBYI) shares owned by Perkins Capital Management from 13F filings

Historical chart of Perkins Capital Management investment in Puma Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Puma Biotechnology held by Perkins Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Puma Biotechnology by Perkins Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $65k 12k 5.31

More positions owned by Perkins Capital Management

Natera (NTRA)
Eli Lilly & Co. (LLY)
Mdxhealth Sa Shs New (MDXH)
Microsoft Corporation (MSFT)
IDEXX Laboratories (IDXX)
Axogen (AXGN)
Skywater Technology (SKYT)
Advanced Micro Devices (AMD)
Abbott Laboratories (ABT)
Magnite Ord (MGNI)
Veracyte (VCYT)
LeMaitre Vascular (LMAT)
Backblaze Com Cl A (BLZE)
Alphatec Hldgs Com New (ATEC)
Digital Turbine Com New (APPS)

View all positions for Perkins Capital Management

Top funds holding Puma Biotechnology

Acorn Capital Advisors
Vanguard Group
BlackRock
Renaissance Technologies
Acadian Asset Management
American Century Companies
Dimensional Fund Advisors
Geode Capital Management
Russell Investments
Connor, Clark & Lunn Investment Management
Kennedy Capital Management
O'shaughnessy Asset Management
State Street Corporation
LSV Asset Management
Marshall Wace

View all funds holding Puma Biotechnology